Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Clinical Pharmacology|June 18, 2026
Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participantsLana Tran, Naihan Chen, Jennifer A Winton, et al.Clinical and Translational Science|July 17, 2024
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairmentRajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, et al.Clinical and Translational Science|November 27, 2024
Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokineticsRajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia, et al.Clinical Pharmacology in Drug Development|September 27, 2018
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous InfusionBrett E Houk, Christine W Alvey, Ravi Visswanathan, et al.Headache|October 24, 2025
A phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraineChay Ngee Lim, Gary Mo, Rajinder Bhardwaj, et al.British Journal of Clinical Pharmacology|August 18, 2025
Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participantsDerek Z Yang, Li Zhou, Jennifer A Winton, et al.Pageof 2